GlassScriptPhysician profile
Curtis L Flood
NPI 1013077072
$361.82
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $81.10 · 2021: $122 · 2022: $55.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $138.12 | 2019-2021 | |
| Daiichi Sankyo INC. | $75.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $35.98 | 2019-2020 | |
| Abbvie INC. | $23.27 | 2020 | |
| Evofem Biosciences, INC. | $17.97 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.97 | 2019 | |
| Sage Therapeutics, LLC | $14.55 | 2021 | |
| Exeltis, USA INC. | $14.43 | 2022 | |
| Kci USA, INC. | $13.84 | 2019 | |
| Mission Pharmacal Company | $12.48 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Flood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.